Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
A Small-Molecule Modulator of Poly-α2,8-Sialic Acid Expression on Cultured Neurons and Tumor Cells
2001 StandoutScienceNobel
Serotonin Transporter Genetic Variation and the Response of the Human Amygdala
2002 StandoutScience
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
2020 StandoutScience
5-Hydroxytryptamine 1A Receptors, Major Depression, and Suicidal Behavior
2005
Consensus paper of the WFSBP Task Force on Biological Markers: Biological Markers in Depression
2007
Depression
2018 Standout
Escitalopram
2005
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Functional polymorphism in the serotonin transporter promoter at the SLC6A4 locus and mood disorders
1998
Imaging phenotypes of major depressive disorder: genetic correlates
2009
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
“Selective” serotonin 5-HT2A receptor antagonists
2022
Adrenergic α2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
1998 StandoutNobel
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Effect of lithium augmentation on the trace elemental profile in diabetic rats
1999
Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635
2000
CSF magnesium in affective disorder: Lack of correlation with clinical course of treatment
1994
Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes
1993
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
2008
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Primary structure of the serotonin transporter in unipolar depression and bipolar disorder
1995
Attempted Suicide Characteristics and Cerebrospinal Fluid Amine Metabolites in Depressed Inpatients
1996
Cellular and molecular pathobiology of pulmonary arterial hypertension
2004 Standout
Distribution of the Glucose‐1,6‐Bisphosphate System in Brain and Retina
1988 StandoutNobel
Serotonin Uptake and Serotonin Uptake Inhibition
1990
Pindolol is a potent scavenger of reactive nitrogen species
2005
The adolescent brain and age-related behavioral manifestations
2000 Standout
Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia
2004
Molecular Dynamics Simulation for All
2018 Standout
Quantitative autoradiography of 3H-paroxetine binding sites in rat brain
1992
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Sodium-Dependent Neurotransmitter TRANSPORTERS: OLIGOMERIZATION as a Determinant of Transporter Function and Trafficking
2004
Insights into the ageing mind: a view from cognitive neuroscience
2004 Standout
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Estradiol-17β increase serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain
1997
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
Clomipramine and mianserin in chronic idiopathic pain syndrome
1989
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
2005 StandoutNature
Self-harm and suicide in adolescents
2012 Standout
X-ray structures and mechanism of the human serotonin transporter
2016 Nature
Recognition of Conserved Amino Acid Motifs of Common Viruses and Its Role in Autoimmunity
2005 StandoutNobel
Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication
1995
Greater Loss of 5-HT2A Receptors in Midlife Than in Late Life
2002
Habenula “Cholinergic” Neurons Corelease Glutamate and Acetylcholine and Activate Postsynaptic Neurons via Distinct Transmission Modes
2011
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
1996
Major Depressive Disorder
2008 Standout
The neural basis of psychedelic action
2022 Standout
Meta-analyses of genetic studies on major depressive disorder
2007
The cognitive control of emotion
2005 Standout
Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis
1999 Standout
Meta-analysis of serotonin transporter polymorphisms and affective disorders
2004
Increased levels of SNAP‐25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder
2006
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography
1998
The interpersonal theory of suicide.
2010 Standout
Neural cell adhesion molecule (NCAM) as a quantitative marker in synaptic remodeling
1995
Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets
1994
Aminergic systems in Alzheimer's disease and Parkinson's disease
1987
Cardiovascular, neuroendocrine, and monoaminergic responses to psychological stressors: Possible differences between remitted panic disorder patients and healthy controls
1996
The molecular neurobiology of depression
2008 StandoutNature
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Estrogen Actions in the Central Nervous System1
1999 Standout
Autoradiographic analyses of the effects of estradiol benzoate on [3H]paroxetine binding in the cerebral cortex and dorsal hippocampus of gonadectomized male and female rats
1993
Optogenetics in Neural Systems
2011 Standout
Elevated Central Serotonin Transporter Binding Availability in Acutely Abstinent Cocaine-Dependent Patients
2000
The molecular pathology of Alzheimer's disease
1991 Standout
Fluorine in medicinal chemistry
2007 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Differential Ontogenesis of Three DOI-Induced Behaviors in Mice
1996
Magnesium in Man: Implications for Health and Disease
2014 Standout
Primary Prevention of Ischemic Stroke
2001
Pharmacological interventions for somatoform disorders in adults
2014 Standout
PET study on central processing of pain in trigeminal neuropathy
1999
Mutations in theCaenorhabditis elegansSerotonin Reuptake Transporter MOD-5 Reveal Serotonin-Dependent and -Independent Activities of Fluoxetine
2001 StandoutNobel
Characterization of [3H]paroxetine binding to rat cortical membranes
1985
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
Escitalopram versus citalopram: the surprising role of the R-enantiomer
2004
Induction of Obesity by Psychotropic Drugs
1987
Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats.
1985
Metabolic and electrolyte changes produced by lithium ions in the isolated rat diaphragm
1975
Lithium action on glucose uptake in brain; Role of glucose-1,6-P2 as a regulator of hexokinase
1980 StandoutNobel
Overexpression of the 5-Hydroxytryptamine Transporter Gene
2004
The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
2011 Standout
Selective serotonin reuptake inhibitors in affective disorders — I. Basic pharmacology
1998
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Stimulation by lithium ions of the incorporation of [U-14C]glucose into glycogen in rat brain slices
1978
α1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates
2002
Primary Prevention of Ischemic Stroke
2001
Pharmacology and Toxicology of Lithium
1976
Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands
1982 Standout
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Transmembrane Domain I Contributes to the Permeation Pathway for Serotonin and Ions in the Serotonin Transporter
1999
Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts
1985
Pathophysiology of the Aquaporin Water Channels
1996 StandoutNobel
Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
2003 StandoutScience
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Structure−Activity Relationships for a Novel Series of Citalopram (1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) Analogues at Monoamine Transporters
2010
Aquaporins in the Kidney: From Molecules to Medicine
2002 StandoutNobel
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
1987 StandoutScience
Elevated Anticardiolipin Antibody Titer Is a Stroke Risk Factor in a Multiethnic Population Independent of Isotype or Degree of Positivity
1999
Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
1994
Works of Per Plenge being referenced
A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression
2012
Pindolol and the acceleration of the antidepressant response
2002
Brain 5-HT1A, 5-HT1D, and 5-HT2 Receptors in suicide victims
1994
A single nucleotide polymorphism in the human serotonin transporter introduces a new site for N-linked glycosylation
2009
The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse
2014
Allosteric effects of R- and S-citalopram on the human 5-HT transporter: Evidence for distinct high- and low-affinity binding sites
2007
Why some depressed patients may have low platelet 3H‐imipramine binding
1990
Binding characteristics of the 5‐HT2A receptor antagonists altanserin and MDL 100907
2005
Imipramine binding in depression and other psychiatric conditions
1988
Characterization of an allosteric citalopram‐binding site at the serotonin transporter
2004
Lithium treatment regimens induce different changes in [3H]paroxetine binding protein and other rat brain proteins
1992
Effect of aging in human cortical pre- and postsynaptic serotonin binding sites
1993
Platelet serotonin transporters and the transporter gene in control subjects, unipolar patients and bipolar patients
2001
[3H]Imipramine binding in idiopathic pain syndromes. Basal values and changes after treatment with antidepressants
1989
Steric Hindrance Mutagenesis in the Conserved Extracellular Vestibule Impedes Allosteric Binding of Antidepressants to the Serotonin Transporter
2012
Characterization of Epibatidine Binding to Medial Habenula: Potential Role in Analgesia
2002
Lithium prophylaxis of manic‐depressive disorder: daily lithium dosing schedule versus every second day
1995
WHO Pilot Study on the Validity of Imipramine Platelet Receptor Binding Sites as a Biological Marker of Endogenous Depression
1988
Regional distribution of the serotonin transport complex in human brain, identified with 3H-Paroxetine, 3H-Citalopram and 3H-Imipramine
1990
Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets
1991
Platelet 3H-imipramine binding in psychogenic pain patients
1988
Lithium action on glycogen synthesis in rat brain, liver, and diaphragm
1970
The activity of 25 paroxetine/femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants
1987
Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes
1985
High affinity binding of3H-paroxetine and3H-imipramine to rat neuronal membranes
1986
Functional and structural rat kidney changes caused by peroral or parenteral lithium treatment
1981
High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes
1983
Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes
1984
Acute Lithium Effects on Rat Brain Glucose Metabolism —in vivo
1976
Lithium effects on calcium, magnesium and phosphate in man: effects on balance, bone mineral content, faecal and urinary excretion
1982
[3H]Citalopram Binding to Brain and Platelet Membranes of Human and Rat
1991
Chlorimipramine--but not imipramine--rapidly reduces imipramine--but not paroxetine--binding in human platelets.
1986